235 related articles for article (PubMed ID: 35679693)
1. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions.
Sachen KL; Arnold Greving CN; Towne JE
Cytokine; 2022 Aug; 156():155897. PubMed ID: 35679693
[TBL] [Abstract][Full Text] [Related]
2. IL-36 cytokines are increased in acne and hidradenitis suppurativa.
Di Caprio R; Balato A; Caiazzo G; Lembo S; Raimondo A; Fabbrocini G; Monfrecola G
Arch Dermatol Res; 2017 Oct; 309(8):673-678. PubMed ID: 28852851
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop.
Hessam S; Sand M; Gambichler T; Skrygan M; Rüddel I; Bechara FG
Br J Dermatol; 2018 Mar; 178(3):761-767. PubMed ID: 28975626
[TBL] [Abstract][Full Text] [Related]
4. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.
Ahmad F; Alam MA; Ansari AW; Jochebeth A; Leo R; Al-Abdulla MN; Al-Khawaga S; AlHammadi A; Al-Malki A; Al Naama K; Ahmad A; Buddenkotte J; Steinhoff M
J Invest Dermatol; 2024 Feb; 144(2):206-224. PubMed ID: 38189700
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis.
Sato S; Chiba T; Nakahara T; Furue M
Australas J Dermatol; 2020 Feb; 61(1):e39-e45. PubMed ID: 31424098
[TBL] [Abstract][Full Text] [Related]
6. The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members.
Mattii M; Ayala F; Balato N; Filotico R; Lembo S; Schiattarella M; Patruno C; Marone G; Balato A
Exp Dermatol; 2013 Dec; 22(12):813-9. PubMed ID: 24164463
[TBL] [Abstract][Full Text] [Related]
7. Targeting IL-36 in Inflammatory Skin Diseases.
Fukaura R; Akiyama M
BioDrugs; 2023 May; 37(3):279-293. PubMed ID: 36867370
[TBL] [Abstract][Full Text] [Related]
8. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases.
Walsh PT; Fallon PG
Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881
[TBL] [Abstract][Full Text] [Related]
9. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
[TBL] [Abstract][Full Text] [Related]
10. Biology of IL-36 cytokines and their role in disease.
Gresnigt MS; van de Veerdonk FL
Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin-36 in health and disease states.
Sugiura K; Fujita H; Komine M; Yamanaka K; Akiyama M
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38779986
[TBL] [Abstract][Full Text] [Related]
12. The Role of New IL-1 Family Members (IL-36 and IL-38) in Atopic Dermatitis, Allergic Asthma, and Allergic Rhinitis.
Tsang MS; Sun X; Wong CK
Curr Allergy Asthma Rep; 2020 Jun; 20(8):40. PubMed ID: 32533268
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
[TBL] [Abstract][Full Text] [Related]
14. Regulation and function of interleukin-36 cytokines.
Bassoy EY; Towne JE; Gabay C
Immunol Rev; 2018 Jan; 281(1):169-178. PubMed ID: 29247994
[TBL] [Abstract][Full Text] [Related]
15. Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis.
Furue K; Yamamura K; Tsuji G; Mitoma C; Uchi H; Nakahara T; Kido-Nakahara M; Kadono T; Furue M
Acta Derm Venereol; 2018 Jan; 98(1):5-13. PubMed ID: 28967976
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoid.
Maglie R; Mercurio L; Morelli M; Madonna S; Salemme A; Baffa ME; Quintarelli L; Di Zenzo GM; Antiga E; Albanesi C
Exp Dermatol; 2023 Jun; 32(6):915-921. PubMed ID: 36940975
[TBL] [Abstract][Full Text] [Related]
17. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-36: Structure, Signaling and Function.
Zhou L; Todorovic V
Adv Exp Med Biol; 2021; 21():191-210. PubMed ID: 32026417
[TBL] [Abstract][Full Text] [Related]
19. Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation.
Zhou L; Todorovic V; Kakavas S; Sielaff B; Medina L; Wang L; Sadhukhan R; Stockmann H; Richardson PL; DiGiammarino E; Sun C; Scott V
J Biol Chem; 2018 Jan; 293(2):403-411. PubMed ID: 29180446
[TBL] [Abstract][Full Text] [Related]
20. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]